Calcium antagonists for acute ischemic heart disease
- PMID: 3881904
- DOI: 10.1016/0002-9149(85)90620-4
Calcium antagonists for acute ischemic heart disease
Abstract
The pharmacologic and physiologic effects of the slow-channel calcium antagonists verapamil, nifedipine and diltiazem are reviewed. Relevant pathophysiologic features of various acute ischemic heart disease syndromes are also reviewed and the clinical applications of the slow-channel calcium antagonists to acute ischemic heart disease syndromes in patients are discussed.
Similar articles
-
The role of calcium antagonists in the treatment of myocardial ischemia.Am Heart J. 1989 Nov;118(5 Pt 2):1093-6; discussion 1096-7. doi: 10.1016/0002-8703(89)90832-6. Am Heart J. 1989. PMID: 2683702 Review.
-
Calcium antagonists for Prinzmetal's variant angina, unstable angina and silent myocardial ischemia: therapeutic tool and probe for identification of pathophysiologic mechanisms.Am J Cardiol. 1987 Jan 30;59(3):101B-115B. doi: 10.1016/0002-9149(87)90089-0. Am J Cardiol. 1987. PMID: 3544788 Review.
-
Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.Cardiovasc Drugs Ther. 1988 Jan;1(5):461-91. doi: 10.1007/BF02125731. Cardiovasc Drugs Ther. 1988. PMID: 3154677 Review.
-
Calcium antagonists in the treatment of individuals with ischemic heart disease.Angiology. 1982 Aug;33(8):522-39. doi: 10.1177/000331978203300804. Angiology. 1982. PMID: 6287889 Review.
-
Calcium channel blocking agents: physiologic basis of nursing intervention.Heart Lung. 1985 Jul;14(4):342-50. Heart Lung. 1985. PMID: 3891687 Review.
Cited by
-
[Anti-ischemic effect of verapamil within the scope of interventional recanalization].Herz. 1999 Nov;24(7):581-6. doi: 10.1007/BF03044230. Herz. 1999. PMID: 10609165 German.
-
Protection by verapamil and nifedipine against ischaemia-induced loss of [3H]-(+)-PN 200-110 binding sites in the rat heart.Naunyn Schmiedebergs Arch Pharmacol. 1990 Jan-Feb;341(1-2):137-42. doi: 10.1007/BF00195070. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 2156175
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources